Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: An individual participant data meta-analysis of observational studies

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Brand, Judith S ^a   Rovers, Maroeska M ^a,b   Yeap, Bu B ^c   Schneider, Harald J ^d   Tuomainen, Tomi Pekka ^e   Haring, Robin ^f   Corona, Giovanni ^g   Onat, Altan ^h   Maggio, Marcello ⁱ   Bouchard, Claude ^j   Tong, Peter C Y ^k   Chen, Richard Y T ^l   Akishita, Masahiro ^m   Gietema, Jourik A ⁿ   Gannagé Yared, Marie Hélène ^o   Undeń, Anna Lena ^p   Hautanen, Aarno ^q   Goncharov, Nicolai P ^r   Kumanov, Philip ^s   Chubb, S A Paul ^c   Almeida, Osvaldo P ^t   Wittchen, Hans Ulrich ^u   Klotsche, Jens ^u   Wallaschofski, Henri ^f   Völzke, Henry ^f   Kauhanen, Jussi ^e   Salonen, Jukka T ^v   Ferrucci, Luigi ^w   Van Der Schouw, Yvonne T ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^g UNIVERSITY OF FLORENCE   (Italy)

^h ISTANBUL UNIVERSITY   (Turkey)

ⁱ UNIVERSITY OF PARMA   (Italy)

^j PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^k CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^l GENERAL HOSPITAL   (Singapore)

^m UNIVERSITY OF TOKYO   (Japan)

ⁿ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^o SAINT JOSEPH UNIVERSITY   (Lebanon)

^p Center for Family and Community Medicine   (Sweden)

^q UNIVERSITY OF HELSINKI   (Finland)

^r ENDOCRINOLOGY RESEARCH CENTRE   (Russian Federation)

^s MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^t UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^u DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^v MAS Metabolic Analytical Services Oy   (Finland)

^w NATIONAL INSTITUTE ON AGING   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; INSULIN RESISTANCE; LIFESTYLE; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE; ADULT; AGE; AGED; BLOOD; META ANALYSIS; MIDDLE AGED; ODDS RATIO; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; ODDS RATIO; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; YOUNG ADULT;

EID: 84904249102     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100409     Document Type: Article

References (58)

1. Metabolic syndrome - driving the CVD epidemic. Available: http://www.idf.org/webdata/docs/Diabetes-meta-syndrome.pdf. Last Accessed: 2013 Nov.
2. Mozumdar A, Liguori G (2011) Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 34: 216-219. 10.2337/dc10-0879
3. Lim S, Shin H, Song JH, Kwak SH, Kang SM, et al. (2011) Increasing prevalence of metabolic syndrome in korea: The korean national health and nutrition examination survey for 1998-2007. Diabetes Care 34: 1323-1328. 10.2337/dc10-2109
4. Lorenzo C, Williams K, Hunt KJ, Haffner SM (2006) Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: The san antonio heart study. Diabetes Care 29: 625-630. (Pubitemid 44115364)
5. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414. 10.1016/j.jacc.2006.09.032 (Pubitemid 46135879)
6. Ford ES, Li C, Sattar N (2008) Metabolic syndrome and incident diabetes: Current state of the evidence. Diabetes Care 31: 1898-1904. 10.2337/dc08-0423
7. Li C, Ford ES, Li B, Giles WH, Liu S (2010) Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 33: 1618-1624. 10.2337/dc09-1788
8. Chubb SA, Hyde Z, Almeida OP, Flicker L, Norman PE, et al. (2008) Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: The health in men study. Eur J Endocrinol 158: 785-792. 10.1530/EJE-07-0893 (Pubitemid 351837366)
9. Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB (2008) Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab 93: 3403-3410. 10.1210/jc.2008-0054
10. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT (2005) Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 90: 2618-2623. 10.1210/jc.2004-1158 (Pubitemid 40686299)
11. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, et al. (2003) Sex hormones, inflammation and the metabolic syndrome: A population-based study. Eur J Endocrinol 149: 601-608. (Pubitemid 38054707)
12. Haring R, Volzke H, Felix SB, Schipf S, Dorr M, et al. (2009) Prediction of metabolic syndrome by low serum testosterone levels in men: Results from the study of health in pomerania. Diabetes 58: 2027-2031. 10.2337/db09-0031
13. Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, et al. (2007) Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 92: 3568-3572. 10.1210/jc.2006-2764 (Pubitemid 47435336)
14. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, et al. (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91: 843-850. 10.1210/jc.2005-1326 (Pubitemid 43357748)
15. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27: 1036-1041. (Pubitemid 38579762)
16. Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, et al. (2007) NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 4: 1038-1045. 10.1111/j.1743-6109.2007.00529.x (Pubitemid 47079637)
17. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT (2011) Testosterone, sex hormone-binding globulin and the metabolic syndrome: A systematic review and meta-analysis of observational studies. Int J Epidemiol 40: 189-207. 10.1093/ije/dyq158
18. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, et al. (2011) Testosterone and metabolic syndrome: A meta-analysis study. J Sex Med 8: 272-283. 10.1111/j.1743-6109.2010.01991.x; 10.1111/j.1743-6109.2010.01991.x
19. Onat A, Hergenc G, Karabulut A, Albayrak S, Can G, et al. (2007) Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Metabolism 56: 1356-1362. 10.1016/j.metabol.2007.05.020 (Pubitemid 47407754)
20. Schneider HJ, Sievers C, Klotsche J, Bohler S, Pittrow D, et al. (2009) Prevalence of low male testosterone levels in primary care in germany: Cross-sectional results from the DETECT study. Clin Endocrinol (Oxf) 70: 446-454. 10.1111/j.1365-2265.2008.03370.x
21. Wittchen HU, Glaesmer H, Marz W, Stalla G, Lehnert H, et al. (2005) Cardiovascular risk factors in primary care: Methods and baseline prevalence rates - the DETECT program. Curr Med Res Opin 21: 619-630. 10.1185/ 030079905X38187
22. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666-3672. (Pubitemid 30645223)
23. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644
24. Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, et al. (2003) Sociodemographic and psychosocial factors are associated with features of the metabolic syndrome. the women's health in the lund area (WHILA) study. Diabetes Obes Metab 5: 106-112. (Pubitemid 36372502)
25. Tierney J, Kass PE, Kadane JB (1989) Approximate marginal densities of nonlinear functions. Biometrika 76: 425-433.
26. Akishita M, Fukai S, Hashimoto M, Kameyama Y, Nomura K, et al. (2010) Association of low testosterone with metabolic syndrome and its components in middle-aged japanese men. Hypertens Res 33: 587-591. 10.1038/hr.2010.43
27. Chen RY, Ng KK (2010) Self-referred older asian males in a men's health clinic: The inter-relationships between androgens, metabolic parameters and quality of life measures. Aging Male 13: 233-241. 10.3109/13685538.2010.487550
28. Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, et al. (2008) Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med 5: 2454-2463. 10.1111/j.1743-6109.2008.00856.x
29. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, et al. (2008) Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: A randomized controlled trial. JAMA 299: 39-52. 10.1001/jama.2007.51
30. Goncharov NP, Katsya GV, Chagina NA, Gooren LJ (2008) Three definitions of metabolic syndrome applied to a sample of young obese men and their relation with plasma testosterone. Aging Male 11: 118-122. 10.1080/13685530802204629
31. Chen RY, Wittert GA, Andrews GR (2006) Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab 8: 429-435. 10.1111/j.1463-1326.2005.00532.x (Pubitemid 44349235)
32. Gannage-Yared MH, Khalife S, Semaan M, Fares F, Jambart S, et al. (2006) Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 155: 167-176. 10.1530/eje.1.02175 (Pubitemid 44103386)
33. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, et al. (2006) Association between hormones and metabolic syndrome in older italian men. J Am Geriatr Soc 54: 1832-1838. 10.1111/j.1532-5415.2006.00963.x (Pubitemid 44915825)
34. Robeva R, Kirilov G, Tomova A, Kumanov P (2006) Low testosterone levels and unimpaired melatonin secretion in young males with metabolic syndrome. Andrologia 38: 216-220. 10.1111/j.1439-0272.2006.00743.x (Pubitemid 44690785)
35. Nuver J, Smit AJ, Wolffenbuttel BH, Sluiter WJ, Hoekstra HJ, et al. (2005) The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 23: 3718-3725. 10.1200/JCO.2005.02.176
36. Unden AL, Elofsson S, Brismar K (2005) Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: A population-based study. Clin Endocrinol (Oxf) 63: 94-102. 10.1111/j.1365- 2265.2005.02306.x
37. Tong PC, Ho CS, Yeung VT, Ng MC, So WY, et al. (2005) Association of testosterone, insulin-like growth factor-I, and C-reactive protein with metabolic syndrome in chinese middle-aged men with a family history of type 2 diabetes. J Clin Endocrinol Metab 90: 6418-6423. 10.1210/jc.2005-0228 (Pubitemid 41759294)
38. Ukkola O, Gagnon J, Rankinen T, Thompson PA, Hong Y, et al. (2001) Age, body mass index, race and other determinants of steroid hormone variability: The HERITAGE family study. Eur J Endocrinol 145: 1-9. (Pubitemid 32677670)
39. Hautanen A (2000) Synthesis and regulation of sex hormone-binding globulin in obesity. Int J Obes Relat Metab Disord 24 Suppl 2: S64-70.
40. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement. J Clin Endocrinol Metab 92: 405-413. 10.1210/jc.2006-1864
41. Huhtaniemi IT, Tajar A, Lee DM, O'Neill TW, Finn JD, et al. (2012) Comparison of serum testosterone and estradiol measurements in 3174 european men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur J Endocrinol 166: 983-991. 10.1530/EJE-11-1051; 10.1530/EJE-11-1051
42. Khosla S, Amin S, Singh RJ, Atkinson EJ, Melton LJ 3rd, et al. (2008) Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density. Osteoporos Int 19: 1465-1471. 10.1007/s00198-008-0591-5; 10.1007/s00198-008-0591-5
43. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, et al. (2003) Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatographymass spectrometry in sera from 116 men, women, and children. Clin Chem 49: 1381-1395. (Pubitemid 36900626)
44. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS (2004) Measurement of total serum testosterone in adult men: Comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 89: 534-543. (Pubitemid 38269854)
45. Veldhuis JD, Bondar OP, Dyer RB, Trushin SA, Klee EW, et al. (2013) Immunological and mass-spectrometric assays of SHBG: Consistent and inconsistent metabolic associations in healthy men. J Clin Endocrinol Metab. 10.1210/jc.2013-2642
46. Haring R, Baumeister SE, Nauck M, Volzke H, Keevil BG, et al. (2013) Testosterone and cardiometabolic risk in the general population - the impact of measurement method on risk associations: A comparative study between immunoassay and mass spectrometry. Eur J Endocrinol 169: 463-470. 10.1530/EJE-13-0222; 10.1530/EJE-13-0222
47. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, et al. (2004) Measurement of free testosterone in normal women and women with androgen deficiency: Comparison of methods. J Clin Endocrinol Metab 89: 525-533. (Pubitemid 38269853)
48. Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J, et al. (2004) Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab 6: 208-215. 10.1111/j.1462-8902.2004.00335.x (Pubitemid 38559701)
49. Kaukua J, Pekkarinen T, Sane T, Mustajoki P (2003) Sex hormones and sexual function in obese men losing weight. Obes Res 11: 689-694. 10.1038/oby.2003.98 (Pubitemid 41151594)
50. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, et al. (2005) Increasing insulin resistance is associated with a decrease in leydig cell testosterone secretion in men. J Clin Endocrinol Metab 90: 2636-2641. 10.1210/jc.2004-2190 (Pubitemid 40686302)
51. Isidori AM, Caprio M, Strollo F, Moretti C, Frajese G, et al. (1999) Leptin and androgens in male obesity: Evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 84: 3673-3680. (Pubitemid 30645224)
52. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, et al. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361: 1152-1163. 10.1056/NEJMoa0804381
53. Perry JR, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, et al. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 19: 535-544. 10.1093/hmg/ddp522
54. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, et al. (2001) Factor analysis of the metabolic syndrome: Obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 25: 1782-1788. 10.1038/sj.ijo.0801837 (Pubitemid 33131918)
55. Bhasin S, Jasjua GK, Pencina M, D'Agostino RS, Coviello AD, et al. (2011) Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: The framingham heart study. Diabetes Care 34: 2464-2470. 10.2337/dc11-0888
56. Lappalainen S, Utriainen P, Kuulasmaa T, Voutilainen R, Jaaskelainen J (2008) Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche. J Clin Endocrinol Metab 93: 1304-1309. 10.1210/jc.2007-2707 (Pubitemid 351519725)
57. Soderberg S, Olsson T, Eliasson M, Johnson O, Brismar K, et al. (2001) A strong association between biologically active testosterone and leptin in nonobese men and women is lost with increasing (central) adiposity. Int J Obes Relat Metab Disord 25: 98-105. (Pubitemid 32142390)
58. Gabriely I, Ma XH, Yang XM, Rossetti L, Barzilai N (2002) Leptin resistance during aging is independent of fat mass. Diabetes 51: 1016-1021. (Pubitemid 34438344)